Hepatitis C Cured Patient Association

Email

irinkatskhomelidze@gmail.com

Address

Georgia
About Hepatitis C Cured Patient Association

In March 2018 Hepatitis C Cured Patient Association within Georgia HCV elimination project was established. The idea and concept were origins on Georgia Technical Advisory Group meeting in 2017. Association is established by Temur Radiana, Doctor of Biology, Author of the idea, Mr. Irakli Koridze, an economist, Mr. Ezekiel Intskirvell-Chkheidze. These people were treated, along with thousands of other Georgians struggling with HCV;
This mission of association is promoting successful implementation of HCV elimination program in Georgia, raising awareness on viral hepatitis and reduction of stigma and discrimination related to hepatitis in society.
The goals and actives are:
1. Uniting the Patients Cured of HCV and forming a supportive advocacy group;
2. Raising awareness on HCV elimination programme in the population;
3. Reducing stigma and discrimination related to hepatitis in medical institutions and societies;
4. Attracting population to increase awareness of the problem of hepatitis C;
5. Cooperation with governmental, non-governmental organisations and funds to support the communication activities within the HCV elimination programme;
6. Increasing popularity and availability of the successful programmes and disseminating information on new initiatives; cooperation with the EU professional institutions;
7. Sharing the Information and Experience on HCV Elimination in Georgia participating in international meetings and conferences organised by international advocacy organisations;
8. Expansion of the Association by increasing the involvement of cured patients.

We are also having regional meetings and usually are on Georgia TV shows.

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close